Plain-English translation of NCT06773364 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , a medication that helps prevent seizures, can improve recovery if given very early—right in the ambulance—when someone is having a stroke. Researchers are also testing whether the way you are positioned in the ambulance (lying flat versus sitting up) affects your outcome. The goal is to see if these simple early treatments can help protect the brain during a stroke.
Stroke is a medical emergency where every minute counts, and brain damage happens very quickly. This medication might prevent complications like seizures that can happen after stroke, but doctors don't yet know if giving it in the ambulance—before reaching the hospital—makes a real difference in how well people recover.
You likely qualify if…
You likely don't qualify if…
If you enter this trial, paramedics in the ambulance will randomly assign you to receive either the medication or standard care, and to either lie flat or sit up during transport to the hospital. You'll receive the medication in the ambulance and then continue taking it twice daily for 14 days after hospital admission (or until you leave the hospital early). Your progress will be tracked over the following weeks and months to see how well you recover from your stroke.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China